Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hot Flashes × Desvenlafaxine Succinate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Hypertension 1 Hot Flashes 1 Diabetes Mellitus 1 Depressive Disorder, Major 1 Depression 1 Cardiovascular Diseases 1 Breast Neoplasms 1

Interventions

Venlafaxine Hydrochloride 2 Bupivacaine 2 Therapeutics 1 Sugars 1 Soybean Proteins 1 Sodium Chloride 1 Moxifloxacin 1 Isoflavones 1 Hypericum extract LI 160 1 Gabapentin 1 Desvenlafaxine Succinate 1 Ciprofloxacin 1 Caseins 1 Amoxicillin-Potassium Clavulanate Combination 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02819921 2019-09-20

Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen

Seoul National University Hospital

Phase 4 Terminated

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡